KolmarBNH콜마비앤에이치

KolmarBNH's shares have fallen about 46% over the past year and trade near their 52-week low, while the latest filings show a trailing loss.

KolmarBNH makes natural-ingredient health functional foods and cosmetics on an ODM/OEM basis, with most sales from those two categories. Trailing twelve-month revenue is about ₩538B with a 6.1% operating margin, but net income is negative at about -₩1.6B, and 2025 revenue and net income both fell. The stock closed at ₩7,560 on 2026-10-23, against a 52-week range of ₩7,450 to ₩15,150.

What stands out

• Revenue fell 6.6% in 2025 to ₩575B, and trailing net income turned negative after a ₩22.7B net loss in 2025.
• Operating profit remains positive, with a trailing operating margin of 6.1%, but the gap to net income suggests non-operating costs or other items weighed on results; the data does not explain the cause.
• Balance sheet figures show cash of ₩76B against borrowings of ₩108B, and liabilities at 49.1% of equity.
• The price-to-book ratio is about 0.6 and the dividend yield about 1%, while the discounted cash flow model gives a base value of ₩13,197, a bear value of ₩5,562 and a bull value of ₩27,050.
• Foreign ownership fell from 4.5% to 2.8% over the last 60 days, and foreign investors were net sellers over the past 20 days.

What to watch

• Next half-year or annual results, to see whether the trailing net loss continues and whether operating margins hold.
• Dividend and share cancellation details from the August filings, and the shareholder record date.
• The September 2026 filing on a 5%+ holding and the August acquisition of shares in another company, which the data does not explain in detail.